HIGHLIGHTS
- who: Correction Publisher Correction from the (UNIVERSITY) have published the Article: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles, in the Journal: (JOURNAL) of 14/03/2017
- what: The authors report here for the first time their use to co-encapsulate drugs, together with their pulmonary application. Because it drastically reduces the dose and the frequency of the treatment, this approach has the potential to diminish the systemic side effects of ETH.
- how: To monitor the activity the authors used two phenotypic assays2943 that rely on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.